A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Are adults (18 to 75 years) with a diagnosis of hidradenitis suppurativa for at... [+2]
Have certain infections or other immune conditions. [+2]